bioLytical Laboratories Inc. receives WHO PQ for its iStatis COVID-19 Antigen Home Test
October 18, 2022 04:00 ET
|
bioLytical Laboratories Inc.
From the makers of INSTI®, bioLytical launches a new platform, iStatis, created to ensure every person in the world has access to reliable testingbioLytical receives eligibility for its self-test, the...
bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test
April 01, 2022 20:00 ET
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today that it is launching a second test on its new platform, iStatis, after receiving Health Canada authorization for the iStatis COVID-19 Antigen Home Test for...
bioLytical Laboratories Inc. erhält CE-Kennzeichnung für iStatis COVID-19-Antigentest für den Heimgebrauch
March 21, 2022 08:31 ET
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. hat heute bekanntgegeben, dass das Unternehmen eine neue Plattform, iStatis, auf den Markt bringt, und hat die CE-Kennzeichnung für den sofortigen Markteintritt in Europa...
bioLytical Laboratories Inc. reçoit son marquage CE pour le test antigénique à domicile de la COVID-19 iStatis
March 21, 2022 08:31 ET
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. a annoncé aujourd'hui le lancement d'une nouvelle plateforme, iStatis, et a reçu son marquage CE pour l'entrée immédiate sur le marché européen de son test antigénique à...
bioLytical Laboratories Inc. Receives its CE Mark for the iStatis COVID-19 Antigen Home Test
March 21, 2022 05:00 ET
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today that it is launching a new platform, iStatis, and has received its CE Mark for immediate market entry into Europe for its iStatis COVID-19 Antigen Home...